ARCHIVES

New NCI Shakeup: O’Connor Leave DCCP to return To International Office; Adamson Acting Director

This article is from The Cancer Letter archive.

Vol. 06 No. 36 | September 12, 1980

Download PDF Visit The Full Archive

Related Articles

Senate Commitee Approves $1.058 Trillion To Reverse Sequestration Cuts

June 21, 2013

Hammer Blast GAO Report As ”Gobblygook”

June 12, 1987

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment

January 25, 2013

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

Clinical Research Group Of ACCC Meets

April 24, 1981